Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibutramine effects on eating behavior in obesity
NCT01170364Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sibutramine in obesity, sponsored by New York State Psychiatric Institute. Started Feb 2009; status: terminated.
02
Drugs
sibutramine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT01170364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01170364.